Table 4.
Mean | SD | Minimum | Quartile 1 | Median | Quartile 3 | Maximum | |
---|---|---|---|---|---|---|---|
% Change in sCTX† | –81.22 | 16.33 | –95.4 | –91.45 | –87.52 | –80.01 | –43.4 |
sCTX, serum C-telopeptide.
Midazolam 2 mg orally on day 1 and day 16, and denosumab 60 mg subcutaneously on day 2.
Including values below the lower limit of quantification (0.2 ng/mL) but above the limit of detection (0.05 ng/mL).